SCHEMBL14884591

SCHEMBL14884591

CC(CO)Cc1ccc(-c2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.44
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MME P08473 4/20 0.37
ADRB1 P08588 2/20 0.37
ADRB3 P13945 2/20 0.37
MAOB P27338 1/20 0.36
SLC2A1 P11166 1/20 0.36
TAAR1 Q96RJ0 2/20 0.36
TRPA1 O75762 1/20 0.36
FFAR4 Q5NUL3 2/20 0.36
ROCK2 O75116 1/20 0.35
PRKACA P17612 1/20 0.35
RPS6KB1 P23443 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13719385 0.82 AKR1C2 (0.53) CHKAAKR1C2AKR1C1RXRARXRB
SCHEMBL2555248 0.81 SLC6A2 (0.57) SLC6A2SLC6A3TAAR1TRPA1
SCHEMBL448921 0.81 SLC6A2 (0.57) SLC6A2SLC6A3TAAR1TRPA1
SCHEMBL23337999 0.80 TRPA1 (0.39) AKR1C2AKR1C1SLC6A2SLC6A3MME
SCHEMBL8283173 0.78 TRPA1 (0.52) MMETRPA1
SCHEMBL14884597 0.77 RXRA (0.50) AKR1C2AKR1C1RXRARXRBS1PR1
SCHEMBL412239 0.75 CHKA (0.53) CHKARXRARXRBS1PR1S1PR5
SCHEMBL14884593 0.75 TP53 (0.51) CHKAAKR1C2AKR1C1RXRARXRB
SCHEMBL14884533 0.75 TP53 (0.51) CHKAAKR1C2AKR1C1RXRARXRB
SCHEMBL14884526 0.75 TP53 (0.51) CHKAAKR1C2AKR1C1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170114006-A1 SUBSTITUTED BIARYL ALKYL AMIDES BIOTHERYX, INC. 2017-04-27 US disclosed
US-9546131-B2 Substituted biaryl alkyl amides BIOTHERYX, INC. (US) 2017-01-17 US disclosed
US-20140336235-A1 SUBSTITUTED BIARYL ALKYL AMIDES BIOTHERYX, INC. 2014-11-13 US disclosed
US-8822527-B2 Substituted biaryl alkyl amides BIOTHERYX, INC. (US) 2014-09-02 US disclosed
US-20130102649-A1 SUBSTITUTED BIARYL ALKYL AMIDES BIOTHERYX, INC. (US) 2013-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114006-A1 SUBSTITUTED BIARYL ALKYL AMIDES AADAC, NAT1, GLS2 CHKA 1423/4885AKR1C2 524/4885AKR1C1 1214/4885
US-20140336235-A1 SUBSTITUTED BIARYL ALKYL AMIDES AADAC, NAT1, GLS2 CHKA 1423/4885AKR1C2 524/4885AKR1C1 1214/4885
US-20130102649-A1 SUBSTITUTED BIARYL ALKYL AMIDES AADAC, NAT1, GLS2 CHKA 1423/4885AKR1C2 524/4885AKR1C1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.